Chelsea Therapeutics Second Quarter Earnings Preview

Chelsea Therapeutics International, Ltd. (NASDAQ:CHTP) will unveil its latest earnings on Monday, July 25, 2011. Chelsea Therapeutics International, Ltd. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products.

Chelsea Therapeutics International, Ltd. Earnings Preview Cheat Sheet

Wall St. Expectations: The average estimate of analysts is for a loss of 25 cents per share. During the past three months, the average estimate has moved down from a loss of 24 cents. Between one and three months ago, the average estimate moved down, but it has been unchanged at a loss of 25 cents during the last month.

Past Earnings Performance: The company is looking to break the streak of missing estimates in the past two quarters. Last quarter, it fell short of analyst expectations by reporting a loss of 25 cents per share against an estimate of net loss of 23 cents per share. The quarter before that, it missed forecasts by 2 cents.

Savvy Investing Tip: Our CHEAT SHEET investing framework recommends only stocks with two straight quarters of earnings growth. Learn More >>

Analyst Ratings: Analysts are bullish on this stock with six analysts rating it as a buy, none rating it as a sell and none rating it as a hold.

Key Stats:

Competitors to Watch: Mylan Inc. (NASDAQ:MYL), Impax Laboratories, Inc. (NASDAQ:IPXL), Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA), Johnson & Johnson (NYSE:JNJ), Bristol Myers Squibb Co. (NYSE:BMY), Abbott Laboratories (NYSE:ABT), Pfizer Inc. (NYSE:PFE), Novartis AG (NYSE:NVS), Amgen, Inc. (NASDAQ:AMGN), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL).

Stock Price Performance: During May 20, 2011 to July 19, 2011, the stock price had risen 96 cents (21.9%) from $4.38 to $5.34. The stock price saw one of its best stretches over the last year between August 13, 2010 and August 23, 2010 when shares rose for seven-straight days, rising 40.7% (+$1.20) over that span. It saw one of its worst periods between March 3, 2011 and March 11, 2011 when shares fell for seven-straight days, falling 10% (-41 cents) over that span. Shares are down $2.16 (-28.8%) year to date.

(Source: Xignite Financials)

Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!